These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 9345349)

  • 1. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras mutation in tamoxifen-related endometrial polyps.
    Hachisuga T; Miyakawa T; Tsujioka H; Horiuchi S; Emoto M; Kawarabayashi T
    Cancer; 2003 Nov; 98(9):1890-7. PubMed ID: 14584071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
    Cohen I
    Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid receptor expression in endometria from women treated with tamoxifen.
    Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ
    Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
    McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
    Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
    Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Raĭcheva S; Marinov E; Gorchev G
    Akush Ginekol (Sofiia); 2004; 43(2):33-6. PubMed ID: 15185527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF; Lin HH; Torng PL; Huang SC
    Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tamoxifen and giant endometrial polyps].
    Caschetto S; Cassaro N; Consalvo P; Caragliano L
    Minerva Ginecol; 2000 Nov; 52(11):459-63. PubMed ID: 11256174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
    Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
    Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
    Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen and endometrial pathologies: a prospective study.
    Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H
    Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters.
    Gul A; Ugur M; Iskender C; Zulfikaroglu E; Ozaksit G
    Arch Gynecol Obstet; 2010 Mar; 281(3):479-83. PubMed ID: 19506890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
    Sant'Ana de Almeida EC; Nogueira AA; Candido dos Reis FJ; Zambelli Ramalho LN; Zucoloto S
    Maturitas; 2004 Nov; 49(3):229-33. PubMed ID: 15488351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
    Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
    Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.